BR112016006955A2 - compostos de marcação e seu uso em ensaios - Google Patents

compostos de marcação e seu uso em ensaios

Info

Publication number
BR112016006955A2
BR112016006955A2 BR112016006955A BR112016006955A BR112016006955A2 BR 112016006955 A2 BR112016006955 A2 BR 112016006955A2 BR 112016006955 A BR112016006955 A BR 112016006955A BR 112016006955 A BR112016006955 A BR 112016006955A BR 112016006955 A2 BR112016006955 A2 BR 112016006955A2
Authority
BR
Brazil
Prior art keywords
compounds
testing
marking compounds
assays
functionalized derivatives
Prior art date
Application number
BR112016006955A
Other languages
English (en)
Portuguese (pt)
Inventor
J Marsh Barrie
G Frost Christopher
Sharp Jonathan
Original Assignee
Atlas Genetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1317787.8A external-priority patent/GB201317787D0/en
Priority claimed from GB201413931A external-priority patent/GB201413931D0/en
Application filed by Atlas Genetics Ltd filed Critical Atlas Genetics Ltd
Publication of BR112016006955A2 publication Critical patent/BR112016006955A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3276—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/113—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being electroactive, e.g. redox labels

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
BR112016006955A 2013-10-08 2014-10-08 compostos de marcação e seu uso em ensaios BR112016006955A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1317787.8A GB201317787D0 (en) 2013-10-08 2013-10-08 Labelling compounds and their use in assays
GB201413931A GB201413931D0 (en) 2014-08-06 2014-08-06 Labelling compounds and their use in assays
PCT/GB2014/053031 WO2015052516A1 (en) 2013-10-08 2014-10-08 Labelling compounds and their use in assays

Publications (1)

Publication Number Publication Date
BR112016006955A2 true BR112016006955A2 (pt) 2017-08-01

Family

ID=51726852

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016006955A BR112016006955A2 (pt) 2013-10-08 2014-10-08 compostos de marcação e seu uso em ensaios

Country Status (10)

Country Link
US (3) US9822398B2 (cg-RX-API-DMAC7.html)
EP (1) EP3055317B1 (cg-RX-API-DMAC7.html)
JP (1) JP2016540724A (cg-RX-API-DMAC7.html)
CN (1) CN105722847A (cg-RX-API-DMAC7.html)
AU (1) AU2014333542B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016006955A2 (cg-RX-API-DMAC7.html)
CA (1) CA2924750A1 (cg-RX-API-DMAC7.html)
EA (1) EA201690434A1 (cg-RX-API-DMAC7.html)
ES (1) ES2663397T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015052516A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021896D0 (en) 2010-12-22 2011-02-02 Atlas Genetics Ltd Novel compounds and their use in analytical methods
HRP20211466T1 (hr) * 2015-12-09 2021-12-24 Medizinische Universität Wien Spojevi platine funkcionalizirani monomaleimidom, namijenjeni terapiji raka
CN106866748B (zh) * 2017-03-29 2018-05-15 厦门云凡医药科技有限公司 化合物的制备方法
CN112630283B (zh) * 2020-12-18 2023-01-17 河南城建学院 (e, e)-1,1′-双(2-吡啶乙烯基)二茂铁作为电化学传感器的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855770T2 (de) * 1987-03-31 1997-05-07 Idemitsu Kosan Co Ferrocenderivate, diese enthaltende oberflächenaktive stoffe und verfahren zur herstellung dünner organischer filme
JPH0283386A (ja) * 1988-09-20 1990-03-23 Idemitsu Kosan Co Ltd 新規フェロセン誘導体,それを含有する界面活性剤及び有機薄膜の製造方法
US6753143B2 (en) * 2000-05-01 2004-06-22 Clinical Micro Sensors, Inc. Target analyte detection using asymmetrical self-assembled monolayers
US20030143556A1 (en) 2001-04-03 2003-07-31 Gary Blackburn Nucleic acid reactions using labels with different redox potentials
GB0205455D0 (en) 2002-03-07 2002-04-24 Molecular Sensing Plc Nucleic acid probes, their synthesis and use
GB0316075D0 (en) 2003-07-09 2003-08-13 Molecular Sensing Plc Protease detection assay
FR2888240B1 (fr) * 2005-07-11 2007-09-07 Biomerieux Sa Monomeres electropolymerisables solubles en solution aqueuse et sondes electroactives susceptibles d'etre obtenues avec de tels monomeres
EP2220102B1 (en) * 2007-11-06 2014-04-16 Clinical Micro Sensors, Inc. Baseless nucleotide analogues and uses thereof
GB0922097D0 (en) 2009-12-17 2010-02-03 Atlas Genetics Ltd Microbial assay
GB201021896D0 (en) * 2010-12-22 2011-02-02 Atlas Genetics Ltd Novel compounds and their use in analytical methods
GB201211157D0 (en) 2012-06-22 2012-08-08 Atlas Genetics Ltd Novel compounds and their use in analytical methods

Also Published As

Publication number Publication date
US11572592B2 (en) 2023-02-07
CN105722847A (zh) 2016-06-29
EA201690434A1 (ru) 2016-08-31
AU2014333542B2 (en) 2019-08-01
JP2016540724A (ja) 2016-12-28
EP3055317B1 (en) 2018-01-31
WO2015052516A1 (en) 2015-04-16
US20220025440A1 (en) 2022-01-27
EP3055317A1 (en) 2016-08-17
US9822398B2 (en) 2017-11-21
US20160244815A1 (en) 2016-08-25
CA2924750A1 (en) 2015-04-16
ES2663397T3 (es) 2018-04-12
US10968490B2 (en) 2021-04-06
US20180037937A1 (en) 2018-02-08
AU2014333542A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
CY1121390T1 (el) Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων
MX2016004933A (es) Inhibidores de pirimidina del fgfr4.
CL2017000654A1 (es) Indazoles sustituidos con bencilo como inhibidores de bub1.
DK3054936T5 (da) 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
CL2016000925A1 (es) Inhibidores de bromodominio
CR20160099A (es) Formulación de inhibidores de la syk
CU20130044A7 (es) Proceso para la preparación de inhibidores de pan-cdk de fórmula (i), e intermediarios de la preparación
UY31806A (es) Compuestos de tiazole y oxazole de sulfonamida de benceno
DK3003038T3 (da) 2h-1,2,3-triazolderivater som inhibitorer af fibrose
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos
BR112015028171A8 (pt) Inibidores de acc e seu uso
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
BR112014003693A2 (pt) amino quinazolinas como inibidores de quinase
CR20140217A (es) Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas ii
AR093446A1 (es) Anticuerpos de antihemaglutinina y metodos de uso
MX372823B (es) Derivados de ácido borónico.
BR112015003655A2 (pt) composto; uso de um composto; e composição farmacêutica
CR20160070A (es) Compuestos de triazolopiridina, composiciones y métodos de uso de los mismos
CR20160083A (es) Compuestos con actividad pesticida
BR112013018616A2 (pt) adesivo com base em solvente contendo gluconato de clorexidina
BR112015001135A2 (pt) inibidores de histona deacetilase e composições e métodos de uso dos mesmos
MX2015003039A (es) Proceso para la reducción de derivados nitro a aminas.
DOP2012000260A (es) Uso de nuevos inhibidores de pan–cdk para tratar tumores
BR112014017802A2 (pt) antígeno, molécula, vetor, célula hospedeira, método de produção de um antígeno, composição, método para detectar, uso de um antígeno e kit
BR112015024109A2 (pt) derivados de ureia e seu uso como inibidores de proteína de ligação de ácidos graxos (fabp)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2535 DE 06-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.